These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2738152)

  • 1. Human neutrophils contain and bind high molecular weight kininogen.
    Gustafson EJ; Schmaier AH; Wachtfogel YT; Kaufman N; Kucich U; Colman RW
    J Clin Invest; 1989 Jul; 84(1):28-35. PubMed ID: 2738152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.
    Gustafson EJ; Lukasiewicz H; Wachtfogel YT; Norton KJ; Schmaier AH; Niewiarowski S; Colman RW
    J Cell Biol; 1989 Jul; 109(1):377-87. PubMed ID: 2526132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between the contact system, neutrophils and fibrinogen.
    Colman RW
    Adv Exp Med Biol; 1990; 281():105-20. PubMed ID: 1966352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma.
    Reddigari S; Kaplan AP
    Blood; 1988 May; 71(5):1334-40. PubMed ID: 2451949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of high molecular weight kininogen on human umbilical vein endothelial cells.
    Schmaier AH; Kuo A; Lundberg D; Murray S; Cines DB
    J Biol Chem; 1988 Nov; 263(31):16327-33. PubMed ID: 2460446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High molecular weight kininogen binds to unstimulated platelets.
    Gustafson EJ; Schutsky D; Knight LC; Schmaier AH
    J Clin Invest; 1986 Jul; 78(1):310-8. PubMed ID: 3722381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.
    Maier M; Austen KF; Spragg J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassays of human high and low molecular weight kininogens in plasmas and platelets.
    Kerbiriou-Nabias DM; Garcia FO; Larrieu MJ
    Br J Haematol; 1984 Feb; 56(2):273-86. PubMed ID: 6691922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoblotting of plasma in a pregnant patient with hereditary angioedema.
    Chhibber G; Cohen A; Lane S; Farber A; Meloni FJ; Schmaier AH
    J Lab Clin Med; 1990 Jan; 115(1):112-21. PubMed ID: 1688910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains.
    Schmaier AH; Schutsky D; Farber A; Silver LD; Bradford HN; Colman RW
    J Biol Chem; 1987 Jan; 262(3):1405-11. PubMed ID: 2433279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
    Scott CF; Silver LD; Schapira M; Colman RW
    J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purification and properties of high-molecular-weight rabbit kininogen].
    Egorova TP; Rossinskaia EB; Paskhina TS
    Biokhimiia; 1976 Jul; 41(6):1052-60. PubMed ID: 1027487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated kinin release from human neutrophil elastase-pretreated kininogens by tissue and plasma kallikreins.
    Dulinski R; Suder P; Guevara-Lora I; Rapała-Kozik M; Potempa J; Silberring J; Imamura T; Travis J; Kozik A
    Biol Chem; 2003 Jun; 384(6):929-37. PubMed ID: 12887060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight kininogen is an inhibitor of platelet calpain.
    Schmaier AH; Bradford H; Silver LD; Farber A; Scott CF; Schutsky D; Colman RW
    J Clin Invest; 1986 May; 77(5):1565-73. PubMed ID: 2422211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic studies of human coagulation factor XI and its complex with high molecular weight kininogen.
    Bouma BN; Vlooswijk RA; Griffin JH
    Blood; 1983 Nov; 62(5):1123-31. PubMed ID: 6626744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.
    Tait JF; Fujikawa K
    J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.